These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 67893)

  • 21. Phase I pharmacological and bioavailability study of oral diflomotecan (BN80915), a novel E-ring-modified camptothecin analogue in adults with solid tumors.
    Gelderblom H; Salazar R; Verweij J; Pentheroudakis G; de Jonge MJ; Devlin M; van Hooije C; Seguy F; Obach R; Pruñonosa J; Principe P; Twelves C
    Clin Cancer Res; 2003 Sep; 9(11):4101-7. PubMed ID: 14519632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group.
    Figlin RA; Crowley JJ; Jacobs EL; Muirhead M; Goodwin JW; Rinehart JJ; Livingston RB
    Cancer; 1996 Sep; 78(5):998-1003. PubMed ID: 8780537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.
    Blaney SM; Needle MN; Gillespie A; Sato JK; Reaman GH; Berg SL; Adamson PC; Krailo MD; Bleyer WA; Poplack DG; Balis FM
    Clin Cancer Res; 1998 Feb; 4(2):357-60. PubMed ID: 9516923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary results of a phase I/II clinical trial of paclitaxel and carboplatin in non-small cell lung cancer.
    Natale RB
    Semin Oncol; 1996 Oct; 23(5 Suppl 12):2-6. PubMed ID: 8941402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase I trial of trans-1-diaminocyclohexane oxalato-platinum (l-OHP).
    Mathé G; Kidani Y; Triana K; Brienza S; Ribaud P; Goldschmidt E; Ecstein E; Despax R; Musset M; Misset JL
    Biomed Pharmacother; 1986; 40(10):372-6. PubMed ID: 3580505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
    Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA
    Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of VP-16-213 in malignant lymphoma and melanoma.
    Cecil JW; Quagliana JM; Coltman CA; Al-Sarraf M; Thigpen T; Groppe CW
    Cancer Treat Rep; 1978 May; 62(5):801-3. PubMed ID: 657164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy of advanced squamous carcinoma of the cervix: a phase I-II study of high-dose cisplatin and cyclophosphamide. A pilot study of the Gynecologic Oncology Group.
    Jobson VW; Muss HB; Thigpen JT; Homesley HD; Bundy B
    Am J Clin Oncol; 1984 Aug; 7(4):341-5. PubMed ID: 6540048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I study of twice weekly 5-azacytidine (NSC-102816).
    Vogler WR; Arkun S; Velez-Garcia E
    Cancer Chemother Rep; 1974; 58(6):895-9. PubMed ID: 4141280
    [No Abstract]   [Full Text] [Related]  

  • 30. Phase II study of subcutaneously administered 5-azacytidine (NSC-102816) in patients with metastatic malignant melanoma.
    Bellet RE; Catalano RB; Mastrangelo MJ; Berd D
    Med Pediatr Oncol; 1978; 4(1):11-5. PubMed ID: 75498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase I study of 5-azacytidine (NSC-102816).
    Shnider BI; Baig M; Colsky J
    J Clin Pharmacol; 1976 Apr; 16(4):205-12. PubMed ID: 57124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I study of 5-azacytidine (NSC-102816) using 24-hour continuous infusion for 5 days.
    Lomen PL; Baker LH; Neil GL; Samson MK
    Cancer Chemother Rep; 1975; 59(6):1123-6. PubMed ID: 56988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trial with subcutaneously administered 5-azacytidine (NSC-102816).
    Bellet RE; Mastrangelo MJ; Engstrom PF; Strawitz JG; Weiss AJ; Yarbro JW
    Cancer Chemother Rep; 1974; 58(2):217-22. PubMed ID: 4133839
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase I and pharmacokinetic study of SM-5887, a new anthracycline derivative.
    Inoue K; Ogawa M; Horikoshi N; Mukaiyama T; Itoh Y; Imajoh K; Ozeki H; Nagamine D; Shinagawa K
    Invest New Drugs; 1989 Jul; 7(2-3):213-8. PubMed ID: 2793375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I study of 5-azacytidine (NSC-102816) .
    Weiss AJ; Stambaugh JE; Mastrangelo MJ; Laucius JF; Bellet RE
    Cancer Chemother Rep; 1972 Jun; 56(3):413-9. PubMed ID: 19051503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of 5-azacytidine (NSC-102816) in the treatment of advanced gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Chemother Rep; 1972 Oct; 56(5):649-52. PubMed ID: 4119908
    [No Abstract]   [Full Text] [Related]  

  • 37. Phase II study of fazarabine in advanced head and neck cancer. A Southwest Oncology Group study.
    Kuebler JP; Metch B; Schuller DE; Keppen M; Hynes HE
    Invest New Drugs; 1991 Nov; 9(4):373-4. PubMed ID: 1725172
    [No Abstract]   [Full Text] [Related]  

  • 38. Rhabdomyolysis as a complication of 5-azacytidine.
    Koeffler HP; Haskell CM
    Cancer Treat Rep; 1978 Apr; 62(4):573-4. PubMed ID: 77729
    [No Abstract]   [Full Text] [Related]  

  • 39. Epigenetic Regulation of Driver Genes in Testicular Tumorigenesis.
    von Eyben FE; Kristiansen K; Kapp DS; Hu R; Preda O; Nogales FF
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic alterations as therapeutic targets in Testicular Germ Cell Tumours : current and future application of 'epidrugs'.
    Cardoso AR; Lobo J; Miranda-Gonçalves V; Henrique R; Jerónimo C
    Epigenetics; 2021 Apr; 16(4):353-372. PubMed ID: 32749176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.